Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11802269 Superpiggybac transposase compositions

Patent 11802269 was granted and assigned to Poseida Therapeutics on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Poseida Therapeutics
Poseida Therapeutics
Date Filed
October 29, 2019
Date of Patent
October 31, 2023
Patent Applicant
Poseida Therapeutics
Poseida Therapeutics
Patent Application Number
16667327
Patent Citations
‌
US Patent 8569227 Stabilized fibronectin domain compositions, methods and uses
‌
US Patent 9200059 Fibronectin type III domain based scaffold compositions, methods and uses
‌
US Patent 9234029 Stabilized fibronectin domain compositions, methods and uses
‌
US Patent 9428767 Enhanced nucleic acid constructs for eukaryotic gene expression
‌
US Patent 9534234 Enhanced nucleic acid constructs for eukaryotic gene expression
‌
US Patent 9546382 Hyperactive piggybac transposases
‌
US Patent 9574209 Enhanced nucleic acid constructs for eukaryotic gene expression
‌
US Patent 9580697 Enhanced nucleic acid constructs for eukaryotic gene expression
‌
US Patent 9670503 PiggyBac transposon variants and methods of use
‌
US Patent 9783790 Trichoplusia ni piggybac transposases with reduced integration activity
•••
Patent Inventor Names
Eric M. Ostertag
Devon Shedlock
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11802269
Patent Primary Examiner
‌
Michail A Belyavskyi

Find more entities like US Patent 11802269 Superpiggybac transposase compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo